One of the greatest commodities in the healthcare industry is the provision of medically relevant information to enable critical decision-making that ultimately optimizes patient outcomes.
Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly
Dr Anthony Yanni, senior vice president and global head of patient centricity at Astellas Pharma, returns to Health Innovators to continue his conversation with Healthware’s chief content o
